Iceland· IS-EU/1/20/1471/001-002
Idefirix
A imlifidase product containing imlifidasum inn, registered in Iceland by Hansa Biopharma AB. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Imlifidase is registered in 12 of 19 countries.
Countries holding a registration under ATC L04AA41 (imlifidase), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Imlifidase · ATC L04AA41
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of imlifidase costs, country by country.
Normalised to the WHO defined daily dose (17.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Imlifidase · price per daily dose (17.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$271803.14
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Imlifidasum INN
- Manufacturer
- Hansa Biopharma AB
- Country
- Iceland (IS)
- ATC code
- L04AA41
- ATC class
- Imlifidase
- Defined daily dose
- 17.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imlifidase in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIDEFIRIXHansa Biopharma AB, Lund
- SwitzerlandIdefirix 11 mg, poudre pour solution à diluer pour perfusionIQONE HEALTHCARE SWITZERLAND SA
- SpainIDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONHansa Biopharma Ab
- FinlandIdefirixHansa Biopharma AB
- United KingdomIdefirix 11mg powder for concentrate for solution for infusion vialsHansa Biopharma AB
- IrelandIdefirix 11 mg powder for concentrate for solution for infusionHansa Biopharma AB
- NorwayIdefirixHansa Biopharma AB
- PolandIdefirixHansa Biopharma AB
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Idefirix
- Norway · Idefirix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/580d21aa-72a9-472d-bac6-8c2c9d6ddaba GET /v1/drugs/580d21aa-72a9-472d-bac6-8c2c9d6ddaba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stofn fyrir innrennslisþykkni, lausn",
"source": "lyfjastofnun",
"atc_raw": "L04AA41",
"marketed": false,
"strength": "11 mg",
"ma_number": "EU/1/20/1471/001-002",
"substance": "Imlifidasum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "44068"
}See everything about imlifidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.